Chimeric clocks $4.17M R&D tax rebate from Canberra
Microcap Chimeric Therapeutics (ASX:CHM) has confirmed its receipt of a $4.17 million…
Chimeric Therapeutics Limited (ASX:CHM)
About Chimeric Therapeutics Limited
Key Information
CHM In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 23/12/2024 | Notification regarding unquoted securities - CHM | 15.79KB | 369 |
| 23/12/2024 | Notification of cessation of securities - CHM | 12.87KB | 266 |
| 23/12/2024 | Notification regarding unquoted securities - CHM | 18.65KB | 256 |
| 16/12/2024 | Price Sensitive PS Phase 1B CHM CORE-NK trial advances to newly diagnosed AML | 217.48KB | 8.4K |
| 13/12/2024 | Change of Director's Interest Notice PH | 199.7KB | 756 |
| 13/12/2024 | Notification regarding unquoted securities - CHM | 17.67KB | 316 |
| 11/12/2024 | Change in substantial holding - PH | 228.05KB | 437 |
| 10/12/2024 | Update - Notification regarding unquoted securities - CHM | 15.76KB | 321 |